GB0905954D0 - Treatment of exacerbations of asthma - Google Patents

Treatment of exacerbations of asthma

Info

Publication number
GB0905954D0
GB0905954D0 GBGB0905954.4A GB0905954A GB0905954D0 GB 0905954 D0 GB0905954 D0 GB 0905954D0 GB 0905954 A GB0905954 A GB 0905954A GB 0905954 D0 GB0905954 D0 GB 0905954D0
Authority
GB
United Kingdom
Prior art keywords
exacerbations
asthma
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0905954.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
E Therapeutics PLC
Original Assignee
E Therapeutics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E Therapeutics PLC filed Critical E Therapeutics PLC
Priority to GBGB0905954.4A priority Critical patent/GB0905954D0/en
Publication of GB0905954D0 publication Critical patent/GB0905954D0/en
Priority to PCT/GB2010/000676 priority patent/WO2010116127A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0905954.4A 2009-04-06 2009-04-06 Treatment of exacerbations of asthma Ceased GB0905954D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0905954.4A GB0905954D0 (en) 2009-04-06 2009-04-06 Treatment of exacerbations of asthma
PCT/GB2010/000676 WO2010116127A1 (en) 2009-04-06 2010-04-01 Combination of cetirizine and mefenamic acid for the treatment of exacerbations of asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0905954.4A GB0905954D0 (en) 2009-04-06 2009-04-06 Treatment of exacerbations of asthma

Publications (1)

Publication Number Publication Date
GB0905954D0 true GB0905954D0 (en) 2009-05-20

Family

ID=40750190

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0905954.4A Ceased GB0905954D0 (en) 2009-04-06 2009-04-06 Treatment of exacerbations of asthma

Country Status (2)

Country Link
GB (1) GB0905954D0 (en)
WO (1) WO2010116127A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001517626A (en) * 1997-09-19 2001-10-09 ザ、プロクター、エンド、ギャンブル、カンパニー Compositions and methods for treating respiratory disorders
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
EP1255544B1 (en) * 2000-01-31 2007-03-07 Genaera Corporation Mucin synthesis inhibitors
GB0719518D0 (en) * 2007-10-05 2007-11-14 Therapeutics Ltd E Therapy

Also Published As

Publication number Publication date
WO2010116127A1 (en) 2010-10-14

Similar Documents

Publication Publication Date Title
IL217901A0 (en) Treatment of bdnf-related disorders using laquninimod
IL218575A0 (en) Treatment of cancer
IL217824A0 (en) Treatment of of macrophage-related disorders
ZA201304280B (en) Treatment of jak2-mediated conditions
GB0915515D0 (en) Treatment of vasculoproliferative conditions
ZA201106730B (en) Methods of treatment using combination therapy
PT2435825E (en) Methods of treating diseases
ZA201106294B (en) Treatment of dyskinesia related disorders
IL214664A0 (en) Methods of treating hair related conditions
GB0919097D0 (en) Treatment of hard surfaces
SG173672A1 (en) Novel ortho-aminoamides for the treatment of cancer
IL206491A0 (en) Treatment of produce
IL225896A0 (en) Treatment of mecp2-associated disorders
IL256026B (en) Methods of treatment
GB0901456D0 (en) Treatment of psoriasis
ZA201202213B (en) Treatment of minerals
GB201018622D0 (en) Treatment of liquids
IL200753A0 (en) Treatment of psoriasis
GB0908101D0 (en) Treatment of stress
ZA201202379B (en) Antagonists of dsgs2 for treatment of cancer
PT2536398T (en) Treatment of osteoporosis
GB0901487D0 (en) Asthma Therapy
GB0905954D0 (en) Treatment of exacerbations of asthma
GB0904073D0 (en) Treatment of influenza
GB0902157D0 (en) Treatment of obesity

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)